Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	153.40	437.89	-172.81
Graham Fair Price	67.87	2.51	1.50
PEG	-80.55	0.87	-4.50
Price/Book	-31.10	5.09	7.39
Price/Cash Flow	-102.80	-587.83	-289.85
Prices/Earnings	-72.06	142.75	510.85
Price/Sales	-41.51	29.86	51.06
Price/FCF	-102.80	-587.83	-289.85
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	42.02	0.15	0.10
Operating Margin	177.14	0.06	0.02
ROA	150.18	< 0.005	< 0.005
ROE	< 0.005	< 0.005	146.57
ROIC	< 0.005	< 0.005	399.21
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.08	1.58	-94.79
Dividends QOQ	59.37	0.68	-98.86
EBIT QOQ	1.09	2.29	109.73
EPS QOQ	1.14	1.63	43.66
FCF QOQ	-1.49	0.66	-55.82
Revenue QOQ	-0.27	0.19	-29.87
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	262.99	226.46	-13.89
Days Sales Outstanding (DSO)	105.68	106.50	0.77
Inventory Turnover	0.34	0.40	16.13
Debt/Capitalization	< 0.005	< 0.005	-8.93
Quick Ratio	1.06	1.25	17.98
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.25	5.61	6.90
Cash	0.59	0.61	4.17
Capex	-0.12	-0.06	54.01
Free Cash Flow	-0.13	-0.05	63.68
Revenue	0.76	0.96	25.94
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.74	3.94	5.20
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.28	-8.42	268.56
Naive Interpretation	Member

06 - Financial Health · Bad

Rating